IDENIX PHARMACEUTICALS INC | 3,955 Euro | +0,094 +2,43 % | |
| WKN: A0B7KX ISIN: US45166R2040 Ticker-Symbol: NO9 | Frankfurt | 19.06.13 | 15:32 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 19.06. | Uptrend Call Working As Idenix Pharmaceuticals Stock Rises 18.8% | - | SmarTrend | |
| 10.06. | IDENIX PHARMACEUTICALS INC - 8-K, Current Report | 5 | SEC Filings | |
| 07.06. | Shares of Idenix Pharmaceuticals Receive a Boost, Up 6.8% | 5 | SmarTrend | |
| 05.06. | Why Idenix Is Poised to Pull Back | 8 | Motley Fool | |
| 31.05. | Idenix Pharma Initiates Phase II Study | 5 | Zacks | |
| 31.05. | Idenix Pharmaceuticals' CEO Presents at Deutsche Bank Securities 38th Annual Health Care Conference (Transcript) | 3 | Seeking Alpha | |
| 30.05. | Idenix Pharma Begins Phase II All-Oral Combo Trial of Samatasvir, Simeprevir for HCV Infection | 1 | Benzinga.com | |
| 30.05. | Idenix Pharma (IDIX) Initiates Phase II HELIX-1 | - | StreetInsider.com | |
| 29.05. | Possible Bearish Inside Day Candle Pattern Detected for Idenix Pharmaceuticals | - | SmarTrend | |
| 28.05. | Hot Stock: Idenix Pharmaceuticals, Shares Gain 5.1% | 4 | SmarTrend | |
| 21.05. | Idenix Pharmaceuticals' CEO Presents at UBS Global Healthcare Services Conference (Transcript) | 1 | Seeking Alpha | |
| 16.05. | Idenix Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) | 13 | Seeking Alpha | |
| 08.04. | Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL) | 6 | Benzinga.com | |
| 01.04. | Shares of Idenix Pharmaceuticals Has Fallen Below Previous 52-Week Low | 4 | SmarTrend | |
| 28.03. | Setback for Idenix Pharma | 16 | Zacks | |
| 28.03. | Idenix to proceed with hepatitis C candidate despite patent flap | 5 | bizjournals | |
| 25.03. | Why Idenix Pharmaceuticals Shares Flopped | 16 | Motley Fool | |
| 25.03. | Idenix Pharmaceuticals' CEO Presents Idenix Provides Update on Patent Interference (Transcript) | 2 | Seeking Alpha | |
| 25.03. | Idenix Loses First Phase Of Patent Dispute With Gilead Sciences | 14 | The Street | |
| 22.03. | Idenix Pharma (IDIX) Receives Adverse Decision in HCV Patent Filing; Will Appeal | 4 | StreetInsider.com |
Seite: 1 2 3 4 Weiter >>
68 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MEDIGENE | 0,982 | +1,03 % | Medigene: Kursziel steigt vor Zusammenlegung |
| QIAGEN | 14,785 | +0,58 % | QIAGEN-Aktie kommt wieder auf die Beine! |
| EVOTEC | 2,766 | -0,14 % | Termine 12.6., u.a. Conergy, Evotec, Fraport, Intershop |
| AMGEN | 76,00 | +1,06 % | Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations |
| BIOGEN IDEC | 156,25 | +0,55 % | Iconix Brand Group, Ralph Lauren, DaVita HealthCare Partners, Myriad Genetics and Biogen Idec highlighted as Zacks Bull and Bear of the Day |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von